Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-103770
Filing Date
2025-10-29
Accepted
2025-10-29 16:53:16
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tm2529686d2_424b5.htm 424B5 419230
2 GRAPHIC tm2529686d2_424b5img01.jpg GRAPHIC 11661
3 GRAPHIC tm2529686d2_424b5img02.jpg GRAPHIC 117516
4 GRAPHIC tm2529686d2_424b5img03.jpg GRAPHIC 181519
  Complete submission text file 0001104659-25-103770.txt   848953
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279077 | Film No.: 251430693
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)